Doximity, Inc.
DOCS
Updated: 24/09/2026, 19:49:58
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.
No summaries found.
- Share price
- $26.20
- Market cap
- $4.90B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Jeffrey A. Tangney
- Employees
- 880
- IPO date
- 24/06/2021
- Beta
- 1.248
- Last dividend
- $0.00
- Day range
- $26.13 – $26.96
- 52-week range
- $17.15 – $76.51
- 1-day performance
- -1.41%
- 1-year performance
- 52.74%
- Current drawdown (1Y)
- -65.76%
- CIK
- 0001516513
- CUSIP
- 26622P107
- ISIN
- US26622P1075
- Created
- 07/12/2025, 03:38:05
- Last update
- 24/09/2026, 19:49:58
Track Doximity, Inc. with an AI analyst
See which prediction-market events move DOCS, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue?
Zacks Investment Research • STOCK • 12/06/2026, 14:31:08
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Doximity, Inc. – DOCS
GlobeNewsWire • STOCK • 09/06/2026, 15:47:00
Did Five Below, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewsWire • STOCK • 05/06/2026, 17:29:00
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS
GlobeNewsWire • STOCK • 02/06/2026, 18:51:00
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS
GlobeNewsWire • STOCK • 26/05/2026, 18:45:00
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale?
The Motley Fool • STOCK • 24/05/2026, 14:30:00
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS
PRNewsWire • STOCK • 21/05/2026, 20:40:00
Dr Martens profits jump as turnaround gains grip
Proactive Investors • STOCK • 19/05/2026, 04:53:41
DOCS vs. HIMS: Which Stock Is the Better Value Option?
Zacks Investment Research • STOCK • 15/05/2026, 14:40:52
DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care
Zacks Investment Research • STOCK • 15/05/2026, 14:36:05
Doximity Earnings: Strong AI Signals, But Monetization Still Pending
Seeking Alpha • STOCK • 15/05/2026, 14:20:02
Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down
Zacks Investment Research • STOCK • 14/05/2026, 14:45:57